SCHEMBL1968399

SCHEMBL1968399

O=C(O)c1ccc2[nH]c(Nc3cc(Cl)ccc3Cl)nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.58
AKR1C3 P42330 1/20 0.47
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CHEK2 O96017 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
CSNK2A1 P68400 1/20 0.41
CDH1 P12830 1/20 0.41
APC P25054 1/20 0.41
CTNNB1 P35222 1/20 0.41
TCF7L2 Q9NQB0 1/20 0.41
C1R P00736 1/20 0.41
NHERF1 O14745 1/20 0.41
BCL6 P41182 1/20 0.41
BCOR Q6W2J9 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2924505 0.90 POLB (0.58) POLBAKR1C3NPC1RAB9ACHEK2
SCHEMBL2929913 0.90 POLB (0.68) POLBAKR1C3CHEK2MAPTKDM1A
SCHEMBL1966454 0.86 AKR1C3 (0.54) POLBAKR1C3NPC1RAB9ACSNK2A1
SCHEMBL16318539 0.86 KMT2A (0.51) POLBNPC1RAB9AALDH1A1MAPT
SCHEMBL3132015 0.82 POLB (0.50) POLBAKR1C3NPC1RAB9ACHEK2
SCHEMBL3120881 0.82 POLB (0.54) POLBAKR1C3NPC1RAB9ACHEK2
SCHEMBL3128528 0.82 AKR1C3 (0.52) POLBAKR1C3NPC1RAB9AMAPT
SCHEMBL2929209 0.81 POLB (0.68) POLBAKR1C3CHEK2MAPTBCL6
SCHEMBL1964392 0.80 AKR1C3 (0.55) POLBAKR1C3NPC1RAB9ACSNK2A1
SCHEMBL3264876 0.80 POLB (0.51) POLBAKR1C3NPC1RAB9ACHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US claimed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US claimed
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP claimed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 POLB 3740/4885AKR1C3 1724/4885NPC1 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.